Cargando…

Efficacy of Antibodies Targeting TfR1 in Xenograft Mouse Models of AIDS-Related Non-Hodgkin Lymphoma

SIMPLE SUMMARY: There is an increased risk for the development of certain cancers, including non-Hodgkin lymphoma (NHL), in individuals infected with the human immunodeficiency virus (HIV). Therefore, NHL is considered to be an acquired immunodeficiency syndrome (AIDS)-related malignancy (AIDS-NHL)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Daniels-Wells, Tracy R., Candelaria, Pierre V., Kranz, Emiko, Wen, Jing, Wang, Lan, Kamata, Masakazu, Almagro, Juan C., Martínez-Maza, Otoniel, Penichet, Manuel L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046321/ https://www.ncbi.nlm.nih.gov/pubmed/36980702 http://dx.doi.org/10.3390/cancers15061816

Ejemplares similares

Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents
por: Candelaria, Pierre V., et al.
Publicado: (2021)

Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants
por: Bien-Ly, Nga, et al.
Publicado: (2014)

Age, dose, and binding to TfR on blood cells influence brain delivery of a TfR-transported antibody
por: Faresjö, Rebecca, et al.
Publicado: (2023)

Regulation of mitochondrial morphology and function by Stearoylation of TfR1
por: Senyilmaz, Deniz, et al.
Publicado: (2015)

Rational design of universal immunotherapy for TfR1-tropic arenaviruses
por: Cohen-Dvashi, Hadas, et al.
Publicado: (2020)

Overexpression of MicroRNAs from the miR-17-92 Paralog Clusters in AIDS-Related Non-Hodgkin's Lymphomas
por: Thapa, Dharma R., et al.
Publicado: (2011)

TfR1 interacts with the IKK complex and is involved in IKK–NF-κB signalling
por: Kenneth, Niall S., et al.
Publicado: (2012)

Downregulation of TfR1 promotes progression of colorectal cancer via the JAK/STAT pathway
por: Cui, Can, et al.
Publicado: (2019)

Machine Learning Classifies Ferroptosis and Apoptosis Cell Death Modalities with TfR1 Immunostaining
por: Jin, Jenny, et al.
Publicado: (2022)

Evaluating the effectiveness of transferrin receptor‐1 (TfR1) as a magnetic resonance reporter gene
por: Pereira, Sofia M., et al.
Publicado: (2016)

Expanding virus susceptibility spectrum of MDBK cells by expressing host receptors nectin 4 and TfR
por: Han, Peiyu, et al.
Publicado: (2021)

Identification of a Novel Inhibitor of TfR1 from Designed and Synthesized Muriceidine A Derivatives
por: Wu, Yu, et al.
Publicado: (2022)

Identification and Characterization of Elevated Expression of Transferrin and Its Receptor TfR1 in Mouse Models of Depression
por: Chang, Xin, et al.
Publicado: (2022)

Dual EGFR- and TfR-targeted gene transfer for sodium iodide symporter gene therapy of glioblastoma
por: Spellerberg, Rebekka, et al.
Publicado: (2022)

Evaluation of ferritin and TfR level in plasma neural-derived exosomes as potential markers of Parkinson’s disease
por: Chen, Zhi-ting, et al.
Publicado: (2023)

Ultraviolet radiation exposure and HIV-associated non-Hodgkin lymphoma risk
por: Hussain, Shehnaz K, et al.
Publicado: (2012)

Blood TfR+ exosomes separated by a pH-responsive method deliver chemotherapeutics for tumor therapy
por: Yang, Lijun, et al.
Publicado: (2019)

Elevated numbers of PD-L1 expressing B cells are associated with the development of AIDS-NHL
por: Epeldegui, Marta, et al.
Publicado: (2019)

Author Correction: Elevated numbers of PD-L1 expressing B cells are associated with the development of AIDS-NHL
por: Epeldegui, Marta, et al.
Publicado: (2020)

Elevated serum levels of heat shock protein 70 precede the development of AIDS-non-Hodgkin lymphoma in carriers of the common and highly conserved HLA-B8-DR3 haplotype
por: Aissani, Brahim, et al.
Publicado: (2010)

Anaplastic Thyroid Carcinoma: Current Treatments and Potential New Therapeutic Options with Emphasis on TfR1/CD71
por: Parenti, Rosalba, et al.
Publicado: (2014)

Blood TfR+ exosomes separated by a pH-responsive method deliver chemotherapeutics for tumor therapy: Erratum
por: Yang, Lijun, et al.
Publicado: (2021)

Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer
por: Chen, Fei, et al.
Publicado: (2021)

CDR3 Variants of the TXB2 Shuttle with Increased TfR1 Association Rate and Enhanced Brain Penetration
por: Stocki, Pawel, et al.
Publicado: (2023)

A Fully Human IgE Specific for CD38 as a Potential Therapy for Multiple Myeloma
por: Candelaria, Pierre V., et al.
Publicado: (2023)

Serum levels of several molecules that are associated with B cell activation and inflammation are elevated in AIDS-associated non-Hodgkin’s lymphoma (AIDS-NHL) and predict response to treatment
por: Epeldegui, Marta, et al.
Publicado: (2012)

Expression and Function of the Chemokine, CXCL13, and Its Receptor, CXCR5, in Aids-Associated Non-Hodgkin's Lymphoma
por: Widney, Daniel P., et al.
Publicado: (2010)

Structure prediction of transferrin receptor protein 1 (TfR1) by homology modelling, docking, and molecular dynamics simulation studies
por: AL-Refaei, Maha Ateeq, et al.
Publicado: (2020)

TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer
por: Cheng, Xiaojing, et al.
Publicado: (2020)

Magnetospirillum magneticum as a Living Iron Chelator Induces TfR1 Upregulation and Decreases Cell Viability in Cancer Cells
por: Menghini, Stefano, et al.
Publicado: (2021)

Hepcidin secretion was not directly proportional to intracellular iron-loading in recombinant-TfR1 HepG2 cells: short communication
por: Mehta, Kosha J., et al.
Publicado: (2020)

Correction: TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer
por: Cheng, Xiaojing, et al.
Publicado: (2022)

Enhanced exon skipping and prolonged dystrophin restoration achieved by TfR1-targeted delivery of antisense oligonucleotide using FORCE conjugation in mdx mice
por: Desjardins, Cody A, et al.
Publicado: (2022)

Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy
por: Almagro, Juan C., et al.
Publicado: (2018)

Elevated serum levels of CXCL13 precede HIV-associated non-Hodgkin’s lymphoma
por: Hussain, Shehnaz K, et al.
Publicado: (2010)

T027: High serum levels of Thymus and Activation Related Chemokine (TARC) precede Hodgkin lymphoma diagnosis by several years
por: Diepstra, Arjan, et al.
Publicado: (2022)

Increasing Levels of Serum Heat Shock Protein 70 Precede the Development of AIDS-Defining Non-Hodgkin Lymphoma Among Carriers of HLA-B8-DR3
por: Aissani, Brahim, et al.
Publicado: (2019)

Levels of Murine, but Not Human, CXCL13 Are Greatly Elevated in NOD-SCID Mice Bearing the AIDS-Associated Burkitt Lymphoma Cell Line, 2F7
por: Widney, Daniel P., et al.
Publicado: (2013)

Markers of Immune Activation and Inflammation, and Non-Hodgkin Lymphoma: A Meta-Analysis of Prospective Studies
por: Makgoeng, Solomon B, et al.
Publicado: (2019)

Nanoencapsulated rituximab mediates superior cellular immunity against metastatic B-cell lymphoma in a complement competent humanized mouse model
por: Wen, Jing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c710cl4ea8g43ujhno3pkljm6i